Review Article

Role of Garlic Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach

Table 1

Effects of garlic on lipid levels.

StudyTypeTargetDuration of RxDoseCase/controlOutcome

Mader, (1990) [20]Randomized, placebo-controlled trialHyperlipidemic12 weeks800 mg garlic powder130/131Dec in T. chol level—12%, TG level—17%

Gadkari and Joshi, (1991) [27]Randomized control trialNormal individuals2 months10 gm of raw garlic25/25 Dec T. chol, increase clotting time, and fibrinolytic activity

Rotzsch et al., (1992) [31]Randomized, placebo-controlled, double-blind trialHealthy individuals with low HDL6 weeks900 mg garlic powder12/12Dec TG levels and increase HDL levels

Saradeth et al., (1994) [26]Randomized double-blind study, placebo-controlled trialHealthy individuals with normal lipid levels15 weeks600 mg dried garlic powder34/34T. chol dec from 223 to 214 mg/dL
TG dec from 124 to 118 mg/dL

Steiner et al., (1996) [29]Double-blind crossover trialHyperlipidemic11 months7.2 g aged garlic20/21Dec T. chol 6.1%, dec LDL 4%, systolic BP 5.5% dec, and modest dec in diastolic Bp noticed

Isaacsohn et al., (1998) [38]Randomized, double-blind, placebo-control trialHyperlipidemic12 weeks900 mg garlic powder (Kwai)28/22No change in lipid levels noticed

Berthold et al., (1998) [39]Double-blind, randomized, placebo-controlled trialHyperlipidemic12 weeks10 mg garlic oil12/13No change in lipids or lipoproteins levels noticed

Satitvipawee et al., (2003) [37]Randomized, double-blind, placebo-controlled trialHyperlipidemic4 weeks/12 weeksGarlic extract70/76No dec in T. chol, DL, TG, and HDL levels noticed

Mahmoodi et al., (2006) [30]Clinical trialHyperlipidemic42 daysRaw garlic 5 gm twice daily30Dec T. chol, dec LDL, dec TG, increase HDL level
Reversed after stopping of garlic

Sobenin et al., (2008) [28]Double blinded placebo controlledHyperlipidemic12 weeksAllicor
(600 mg daily)
21/21T. chol 7.6% dec, LDL 11.8%, and HDL inc 11.5%

T. chol: total cholesterol, HDL: high-density lipoprotein, TG: triglyceride, LDL: low-density lipoprotein, and VLDL: very low-density lipoprotein.